Use of capsiate or dihydrocapsidate

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9381168
APP PUB NO 20110028547A1
SERIAL NO

12742245

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a new use of capsiate or dihydrocapsiate, more particularly to a composition for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease or for suppressing immunity comprising capsiate, dihydrocapsiate or a pharmaceutically acceptable salt thereof as an effective ingredient. The composition and immunosuppressant of the present invention may be used for preventing and treating inflammatory disease, angiogenesis-related disease and autoimmune disease, and for suppressing immunity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CATHOLIC UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION505 BANPO-DONG SEOCHO-GU SEOUL

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Tae-Yoon Seoul, KR 95 522
Kwon, Young Guen Seoul, KR 4 13
Pyun, Bo Jeong Seoul, KR 2 1
Shin, Dong Heun Seoul, KR 6 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 5, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00